Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-016776

Director bought 2,500 shares at $6.40 ($16,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2024-05-24 Purchase +2,500 $6.40 $16,000 2,500 I: show line 1 in the form
Open-market purchases · 2,500 sh · avg $6.40 · $16,000
Loading xslF345X05/form4.xml…